Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...
MUD HCT is associated with better survival outcomes and fewer severe complications compared to haploidentical HCT in acute ...
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial ...
We got to know Ellie's struggle with sobriety better when Matlock Season 2 Episode 4's case triggered Matty's memories. Our ...
Actor Pankaj Dheer's passing highlights cancer relapse, a common issue for survivors. Cancer recurrence remains one of the most challenging aspects of this disease, often catching patients and ...
Veteran Bollywood and television actor Pankaj Dheer, fondly remembered for his iconic portrayal of Karna in B.R. Chopra’s Mahabharat, has passed away in Mumbai on October 15, 2025, after a long and ...
Actor Pankaj Dheer, who played Karna in Mahabharat, passed away on October 15. He was sixty-eight. The actor fought cancer for a long time. The news was corroborated by actor Firoz Khan, who portrayed ...
Renowned actor Pankaj Dheer has passed away after a prolonged battle with cancer, drawing attention to why the disease often returns even after successful treatment. Experts say cancer relapse happens ...
The entertainment world is deeply saddened by the news of veteran actor Pankaj Dheer’s passing at 68. Pankaj Dheer, famous for his iconic role as Karna in B.R. Chopra’s Mahabharat, had been battling ...
When we declare a patient "cancer-free," there is always a quiet pause in every oncologist's heart. We celebrate the remission, but we also know that breast cancer, in some women, has a tendency to ...
Researchers at The Institute of Cancer Research have found a dual genetic test is more accurate than the traditional approach in identifying multiple myeloma patients who may be at an elevated risk of ...